tetano
Editor, Senior Moderator
Clin Microbiol Infect. 2013 May 29. doi: 10.1111/1469-0691.12284. [Epub ahead of print]
Modelling during an emergency: the 2009 H1N1 influenza pandemic.
Lee BY, Haidari LA, Lee MS.
Source
Public Health Computational and Operational Research (PHICOR) Group, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Abstract
During the 2009 H1N1 pandemic, decision-makers had access to mathematical and computational models that were not available in previous pandemics in 1918, 1957, and 1968. How did models contribute to policy and action during the 2009 H1N1 pandemic? Modelling encountered six primary challenges: (i) expectations of modelling were not clearly defined; (ii) appropriate real-time data were not readily available; (iii) modelling results were not generated, shared, or disseminated in time; (iv) decision-makers could not always decipher the structure and assumptions of the models; (v) modelling studies varied in intervention representations and reported results; and (vi) modelling studies did not always present the results or outcomes that are useful to decision-makers. However, there were also seven general successes: (i) modelling characterized the role of social distancing measures such as school closure; (ii) modelling helped to guide data collection; (iii) modelling helped to justify the value of the vaccination programme; (iv) modelling helped to prioritize target populations for vaccination; (v) modelling addressed the use of antiviral medications; (vi) modelling helped with health system preparedness planning; and (vii) modellers and decision-makers gained a better understanding of how to work with each other. In many ways, the 2009 pandemic served as practice and a learning opportunity for both modellers and decision-makers. Modellers can continue working with decision-makers and other stakeholders to help overcome these challenges, to be better prepared when the next emergency inevitably arrives.
? 2013 The Authors Clinical Microbiology and Infection ? 2013 European Society of Clinical Microbiology and Infectious Diseases.
PMID:
23800220
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/23800220
Modelling during an emergency: the 2009 H1N1 influenza pandemic.
Lee BY, Haidari LA, Lee MS.
Source
Public Health Computational and Operational Research (PHICOR) Group, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Abstract
During the 2009 H1N1 pandemic, decision-makers had access to mathematical and computational models that were not available in previous pandemics in 1918, 1957, and 1968. How did models contribute to policy and action during the 2009 H1N1 pandemic? Modelling encountered six primary challenges: (i) expectations of modelling were not clearly defined; (ii) appropriate real-time data were not readily available; (iii) modelling results were not generated, shared, or disseminated in time; (iv) decision-makers could not always decipher the structure and assumptions of the models; (v) modelling studies varied in intervention representations and reported results; and (vi) modelling studies did not always present the results or outcomes that are useful to decision-makers. However, there were also seven general successes: (i) modelling characterized the role of social distancing measures such as school closure; (ii) modelling helped to guide data collection; (iii) modelling helped to justify the value of the vaccination programme; (iv) modelling helped to prioritize target populations for vaccination; (v) modelling addressed the use of antiviral medications; (vi) modelling helped with health system preparedness planning; and (vii) modellers and decision-makers gained a better understanding of how to work with each other. In many ways, the 2009 pandemic served as practice and a learning opportunity for both modellers and decision-makers. Modellers can continue working with decision-makers and other stakeholders to help overcome these challenges, to be better prepared when the next emergency inevitably arrives.
? 2013 The Authors Clinical Microbiology and Infection ? 2013 European Society of Clinical Microbiology and Infectious Diseases.
PMID:
23800220
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/23800220